Cellectar Looks to Raise $3.3M
Cellectar Biosciences today announced it is looking to raise $3.3 million through Wednesday by pricing common stock at $2.20 per share. According to a release, the company looks to use the…
Category Archives: Biotech
Stemina Receives $2.7M Grant
Stemina Biomarker Discovery Inc., a company focused on diagnosis and individualized treatment of neurological disorders, received a $2.7 million grant from the National Institute of Mental Health (NIMH) to support the Children’s Autism…
Cellectar CEO to Speak at Investment Conference
Cellectar Biosciences CEO Jim Caruso was chosen to present at the Rodman & Renshaw 17th Annual Global Investment Conference, taking place Sept. 10 in New York City, the organization announced recently. “The…
CDI Launches Largest Stem Cell Bank
Cellular Dynamics International announced today it has launched the California Institute for Regenerative Medicine hPSC Repository, the world’s largest public stem cell bank. According to a release, the repository will make…
FluGen Closes $12M Series A
FluGen announced today that it closed a $12 million Series A financing round. According to a release, the Wisconsin Alumni Research Foundation, the State of Wisconsin Investment Board, Knox LLC and…
Propeller Gets Another FDA Clearance
Propeller Health announced this week that it was cleared by the FDA to market its platform with medications using GlaxoSmithKline’s Diskus dry powder inhaler. “Today we’re excited to announce back-to-back…
Lucigen Lands New Grant
Lucigen announced recently it was awarded an SBIR Phase II grant to continue work on a DNA cloning vector for the growing protein expression market. According to a release, Lucigen…
SHINE Lands $150K Grant
SHINE Medical Technologies has earned a $150,000 SBIR Grant from the National Science Foundation, the medical isotope company announced this week. According to a release, the grant will aid SHINE’s ongoing…
Invenra, OBT to Collaborate
Invenra announced last week that is has teamed up with UK-based biotech company Oxford BioTherapeutics (OBT) to identify and characterize a panel of fully human therapeutic monoclonal antibodies (mAbs) against…
InvivoSciences, Hamamatsu to Collaborate
InvivoSciences and New Jersey-based Hamamatsu today announced a joint collaboration that ultimately may help accelerate preclinical drug discovery in regenerative medicine. According to a release, technology developed by Hamamatsu will be…
